New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Adding dostarlimab improves progression-free survival in endometrial cancer

Adding dostarlimab improves progression-free survival in endometrial cancer

by Elana GotkineFor patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, acc
World medicine December 04,2023
Adding dostarlimab improves progression-free survival in endometrial cancer

Adding dostarlimab improves progression-free survival in endometrial cancer

by Elana GotkineFor patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, acc
World medicine December 04,2023
Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

by International Association for the Study of Lung CancerCredit: CC0 Public DomainResearch findings from the CheckMate 227 trial will be presented at the International Association for the Study of Lun
World medicine December 04,2023
Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

by International Association for the Study of Lung CancerCredit: CC0 Public DomainResearch findings from the CheckMate 227 trial will be presented at the International Association for the Study of Lun
World medicine December 04,2023
Tumor avatars to fight colorectal cancer

Tumor avatars to fight colorectal cancer

byUniversity of GenevaThe research team worked with organoids derived from untreated cancer tissue taken from patients. Credit: UNIGEHow to determine the most effective treatment for colon cance
World medicine December 04,2023
Tumor avatars to fight colorectal cancer

Tumor avatars to fight colorectal cancer

byUniversity of GenevaThe research team worked with organoids derived from untreated cancer tissue taken from patients. Credit: UNIGEHow to determine the most effective treatment for colon cance
World medicine December 04,2023
New program shows promise in reducing financial burden of cancer care

New program shows promise in reducing financial burden of cancer care

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainThe rising cost of cancer care puts patients and their caregivers at increased risk of experiencing financial toxicity,
World medicine December 04,2023
New program shows promise in reducing financial burden of cancer care

New program shows promise in reducing financial burden of cancer care

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainThe rising cost of cancer care puts patients and their caregivers at increased risk of experiencing financial toxicity,
World medicine December 04,2023
Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

byRIKENPathogenic Variant and H. pylori Infection on Gastric Cancer Risk. Credit: RIKENA large case-control study by international researchers at the RIKEN Center for Integrative Medical Science
World medicine December 04,2023
Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

byRIKENPathogenic Variant and H. pylori Infection on Gastric Cancer Risk. Credit: RIKENA large case-control study by international researchers at the RIKEN Center for Integrative Medical Science
World medicine December 04,2023
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

byInstitute of Cancer ResearchProstate cancer cell. Credit: Anne Weston, Francis Crick Institute.A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation gre
World medicine December 04,2023
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

byInstitute of Cancer ResearchProstate cancer cell. Credit: Anne Weston, Francis Crick Institute.A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation gre
World medicine December 04,2023
Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

by Justin Jackson , Medical XpressEarly genomic instability is associated with unfavorable outcome. a, Enrichment of chromosomal aberrations and clinical parameters in early- and late-MRCA tumors pred
World medicine December 04,2023
Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

by Justin Jackson , Medical XpressEarly genomic instability is associated with unfavorable outcome. a, Enrichment of chromosomal aberrations and clinical parameters in early- and late-MRCA tumors pred
World medicine December 04,2023
Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

byNational Cancer InstituteLYG scans. Credit: National Cancer InstituteResults from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low
World medicine December 04,2023
Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

byNational Cancer InstituteLYG scans. Credit: National Cancer InstituteResults from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low
World medicine December 04,2023
A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

byUniversity of SaskatchewanEPHA2, c-MET and EGFR levels in human tumors. (A) RNA-Seq Expectation Maximization (RSEM) normalized expression levels in the log2 scale for EGFR, c-MET and EPHA2 in
World medicine December 04,2023
A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

byUniversity of SaskatchewanEPHA2, c-MET and EGFR levels in human tumors. (A) RNA-Seq Expectation Maximization (RSEM) normalized expression levels in the log2 scale for EGFR, c-MET and EPHA2 in
World medicine December 04,2023
Judge's decision would make some no-cost cancer screenings a thing of the past

Judge's decision would make some no-cost cancer screenings a thing of the past

by Julie Appleby, Michelle AndrewsCredit: CC0 Public DomainA federal judge on Thursday overturned a portion of the Affordable Care Act that makes preventive services, such as some cancer screenings, f
World medicine December 04,2023
Judge's decision would make some no-cost cancer screenings a thing of the past

Judge's decision would make some no-cost cancer screenings a thing of the past

by Julie Appleby, Michelle AndrewsCredit: CC0 Public DomainA federal judge on Thursday overturned a portion of the Affordable Care Act that makes preventive services, such as some cancer screenings, f
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com